News
Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...
Hosted on MSN6mon
Transforming Waste Boxes Into Functional Cardboard Cartons - MSNWatch the technical process of building cardboard cartons using waste carton boxes inside a factory. This method transforms discarded materials into new, functional packaging, showcasing ...
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin ...
Hikma Pharmaceuticals has agreed to pay $50 million to settle a class action accusing the drugmaker of scheming to delay a generic version of Jazz’s blockbuster narcolepsy drug Xyrem, causing ...
British drugmaker Hikma Pharmaceuticals reported a bigger-than-expected profit for 2023 on Thursday, helped by a strong performance of its generics businesses, but expects profit to be slightly ...
Hikma has started construction on the 130,000-square-foot addition to its 1 million-square-foot generic drugmaking complex on the west side of Columbus. Here’s what Amgen says spurred its $5B US ...
Hikma's branded generic will compete with Teva Pharmaceuticals (TEVA.TA), opens new tab authorized generic of Victoza in the United States that was launched earlier this year.
Hikma Pharmaceuticals USA (HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D. Read more details here.
Hikma posted pre-tax profits in the six months to June that nearly doubled to $112m, from $58m in the same period last year, on sales up 20 per cent to $638m, ...
FTSE 100 movers: Smurfit Kappa in the box seat; Hikma out of favour. Fri, 29th Apr 2022 15:33 (Sharecast News) - The FTSE 100 was up 0.78% at 7,567.69 at 1521 BST.
Hikma helps put better health within reach every day for millions of people around the world. ... Carton of six bags. 500 mg/100 mL (5 mg/mL) ... with no box warning and no limitation of use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results